New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
10:04 EDTTSH, RPTP, MYGN, TGI, ITC, ANGI, BBG, SYT, SIRI, CENX, BIRT, VTSS, ETN, OAS, CSGS, AGCOOn the Fly: Analyst Downgrade Summary
AGCO (AGCO) downgraded to Market Perform from Outperform at BMO Capital... Actuate (BIRT) downgraded to Hold from Buy at Drexel Hamilton... Angie's List (ANGI) downgraded to Neutral from Buy at BofA/Merrill... CSG Systems (CSGS) downgraded to Underweight from Neutral at JPMorgan... Century Aluminum (CENX) downgraded to Market Perform from Outperform at Cowen... ITC Holdings (ITC) downgraded to Neutral from Buy at ISI Group... Oasis Petroleum (OAS) downgraded to Buy from Conviction Buy at Goldman... Sirius XM (SIRI) downgraded to Hold from Buy at Wunderlich... Triumph Group (TGI) downgraded to Neutral from Buy at BofA/Merrill... James River Coal (JRCC) downgraded at Sterne Agee... Eaton (ETN) downgraded at MKM Partners... Syngenta (SYT) downgraded to Buy from Conviction Buy at Goldman... Myriad Genetics (MYGN) downgraded to Neutral from Buy at Ladenburg... Vitesse (VTSS) downgraded to Hold from Buy at Craig-Hallum... Bill Barrett (BBG) downgraded to Neutral from Accumulate at Global Hunter... Teche Holding (TSH) downgraded to Market Perform from Outperform at Fig Partners... Raptor Pharmaceuticals (RPTP) downgraded to Underperform from Neutral at Wedbush.
News For AGCO;BIRT;ANGI;CSGS;CENX;ITC;OAS;SIRI;TGI;ETN;SYT;MYGN;VTSS;BBG;TSH;RPTP From The Last 14 Days
Check below for free stories on AGCO;BIRT;ANGI;CSGS;CENX;ITC;OAS;SIRI;TGI;ETN;SYT;MYGN;VTSS;BBG;TSH;RPTP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 11, 2014
08:58 EDTSIRISirius XM debt move clears way for more buybacks, says FBR Capital
Subscribe for More Information
April 10, 2014
10:28 EDTITCITC Holdings to host investor day
Subscribe for More Information
09:37 EDTSIRIActive equity options trading on open
Active equity options trading on open according to Track Data: SIRI RAD AAPL AMZN AA FB TSLA MRK CVX C
April 9, 2014
14:00 EDTAGCOApril WASDE data imply modest row crop cash improvement, says Wells Fargo
Well Fargo estimates that the latest WASDE report from the USDA implies U.S. row crop farmer cash receipts declining 13% in 2013/14 from the prior year, which is a modest improvement from March's implied forecast. The firm notes that the data still suggests an apparent decrease in 2013/2014 farm cash flow and keeps its Underperform ratings on Deere (DE) and AGCO (AGCO).
12:04 EDTSYTU.S. corn exports projected to increase 125M bushels
Subscribe for More Information
April 7, 2014
16:34 EDTMYGNMyriad Genetics submits premarket approval to FDA for BRACAnalysis
Subscribe for More Information
15:49 EDTOASOasis Petroleum sees Q1 production 41-45 MBoepd
Oasis sees FY14 production to average 46-50 MBoepd. Guidance from slides for April investor presentation.
11:09 EDTMYGNMyriad Genetics advises prior BRACAnalysis news release be disregarded
Myriad Genetics advised that readers should disregard the news release, "Myriad Genetics Submits Premarket Approval to FDA for BRACAnalysis" issued April 7 by the company over GlobeNewswire.
10:16 EDTMYGNMyriad Genetics has a conference call hosted by JPMorgan
Subscribe for More Information
05:48 EDTMYGNMyriad Genetics submits premarket approval to FDA for BRACAnalysis
Subscribe for More Information
April 4, 2014
11:07 EDTMYGNMyriad Genetics price target raised to $42 from $34 at Piper Jaffray
Piper Jaffray raised its price target for Myriad Genetics shares to $42 to reflect CMS' recent decision to increase BRCA reimbursement. The firm keeps an Overweight rating on the stock.
10:02 EDTOASOn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:02 EDTMYGNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:20 EDTOASOasis Petroleum initiated with a Neutral at BofA/Merrill
Subscribe for More Information
07:06 EDTRPTPTransgenomic announces collaboration with Raptor Pharmaceuticals
Subscribe for More Information
06:48 EDTMYGNMyriad Genetics upgraded to Buy from Neutral at Mizuho
Subscribe for More Information
06:46 EDTMYGNMyriad Genetics upgraded to Buy from Neutral at Mizuho
05:46 EDTSIRIStocks with implied volatility movement; IBB SIRI
Subscribe for More Information
April 3, 2014
09:04 EDTSIRISirius XM fundamentals remain on track, says Maxim
Subscribe for More Information
07:37 EDTMYGNMyriad Genetics price target raised to $40 from $28 at Mizuho
Mizuho raised Myriad's price target to $40 from $28 following the better than expected CMS pricing for BRCA testing. Shares are Neutral rated.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use